Position in AGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$76,496
-$641,760 QoQ
Shares Held
24,999
-88.4% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 103 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. AGEN ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in AGEN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,496 | 24,999 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $718,256 | 215,047 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,954,599 | 622,484 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $789,600 | 205,091 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $60,650 | 40,166 | Shares | Defined | 2025-05-21 | |
| 2024-09-30 | $39,795 | 7,262 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $439,290 | 757,397 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,517 | 36,768 | Shares | Defined | 2024-02-13 | |
| 2022-09-30 | $506,165 | 246,910 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,420,680 | 1,247,775 | Shares | Defined | 2022-08-09 | |
| 2021-12-31 | $32,393 | 10,060 | Shares | Defined | 2022-02-10 | |
| 2020-12-31 | $318,149 | 100,047 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,519,675 | 379,919 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $3,075,097 | 782,468 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||